Company Description
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.
The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.
Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices.
The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Country | United States |
IPO Date | Oct 22, 2021 |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 174 |
CEO | Darrin Hammers |
Contact Details
Address: 4255 Burton Drive Santa Clara, California United States | |
Website | https://minervasurgical.com |
Stock Details
Ticker Symbol | UTRS |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001452965 |
CUSIP Number | 60343F106 |
ISIN Number | US60343F1066 |
Employer ID | 26-3422906 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Darrin Hammers | Chief Executive Officer |
Brent Palmisano | Chief Commercial Officer |
Dr. Evgueni V. Skalnyi M.D. | Chief Medical Officer |
Erik Reese | Vice President of Sales |
Greg Simbro | Vice President of Finance |
Joanne Long | Vice President of Corporate Controller |
Wendy Bowman | Vice President of Human Resources |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jan 04, 2024 | 15-12G | Filing |
Dec 26, 2023 | 25 | Filing |
Dec 26, 2023 | S-8 POS | Filing |
Dec 15, 2023 | 8-K | Current Report |
Nov 13, 2023 | 10-Q | Quarterly Report |
Nov 13, 2023 | 8-K | Current Report |
Nov 02, 2023 | SC 13E3/A | [Amend] Filing |
Nov 02, 2023 | 8-K | Current Report |
Oct 13, 2023 | 8-K | Current Report |
Sep 29, 2023 | 8-K | Current Report |